4.5 Article

Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates MicroRNA-125a-5p in Polarized Monocyte Phenotypes

Journal

ARTHRITIS & RHEUMATOLOGY
Volume 68, Issue 9, Pages 2300-2313

Publisher

WILEY
DOI: 10.1002/art.39694

Keywords

-

Categories

Funding

  1. NIH (National Heart, Lung, and Blood Institute grant) [K12-HL-119986]
  2. Rheumatology Research Foundation (Scientist Development award)
  3. NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases grant) [P01-AR-048929, R01-AR-059049]
  4. AbbVie
  5. AstraZeneca
  6. Centocor
  7. Bristol-Myers Squibb
  8. Pfizer
  9. Regeneron
  10. Hoffmann-La Roche
  11. Novartis
  12. UBC
  13. Xoma
  14. Genentech
  15. Wyeth Pharmaceuticals
  16. NovImmune

Ask authors/readers for more resources

Objective. Systemic juvenile idiopathic arthritis (JIA) is an inflammatory disease of childhood in which cells of the monomyelocytoid lineage are thought to be key effector cells. Monocytes from patients with systemic JIA have a distinct phenotype, with features of both M1 and M2 alternative activation. MicroRNAs are critical regulators of monocyte polarization and function, but cellular microRNAs in systemic JIA have not been examined systematically. Methods. MicroRNA TaqMan arrays were used to determine the expression profiles of monocytes from children with systemic JIA. Expression of microRNA-125a-5p (miR-125a-5p) and its contribution to monocyte polarization were examined using in vitro-polarized THP-1 cells and primary human monocytes. Results. A total of 110 microRNAs were found to be differentially expressed in monocytes from patients with active systemic JIA, including molecules implicated in rheumatoid arthritis pathogenesis, cytokine production, and monocyte polarization. MicroRNA-125a-5p was identified as being highly up-regulated in monocytes from children with active systemic JIA, as compared to those from children with clinically inactive JIA or those with active polyarticular JIA, and correlated with systemic features of the disease. In vitro, monocyte miR125a-5p expression was increased after polarization under M2b or M2c conditions. Inhibition of miR-125a-5p showed that this microRNA contributed to full polarization of M2b regulatory macrophages. In contrast, miR-125a-5p overexpression enhanced M2b polarization and altered other polarized populations, including increasing the production of M2 markers. Indeed, in vitro overexpression of this microRNA altered the macrophage phenotype toward that observed in systemic JIA. Conclusion. Children with active systemic JIA have profound alterations in the expression of microRNAs that are implicated in monocyte function and polarization. One of these microRNAs, miR-125a-5p, is also a regulator of immunoregulatory M2b macrophages.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available